Achilles Therapeutics plc - American Depositary Shares, each representing one ordinary share, nominal value of 0.001 per share (ACHL)

32 filings reported holding ACHL - Achilles Therapeutics plc - American Depositary Shares, each representing one ordinary share, nominal value of 0.001 per share as of Q1 2024.
Achilles Therapeutics plc - American Depositary Shares, each representing one ordinary share, nominal value of 0.001 per share (ACHL) has 31 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC). These institutions hold a total of 23.5M shares of 41.1M outstanding shares and own 57.17% of the company stock.
Largest 10 shareholders include Syncona Portfolio Ltd (11.1M shares), FCPM III SERVICES B.V. (2.39M shares), Redmile Group, LLC (1.61M shares), Vestal Point Capital, LP (1.5M shares), Ikarian Capital, LLC (1.44M shares), STEMPOINT CAPITAL LP (1.39M shares), BAKER BROS. ADVISORS LP (1.21M shares), RENAISSANCE TECHNOLOGIES LLC (1.01M shares), Artal Group S.A. (755K shares), and BOOTHBAY FUND MANAGEMENT, LLC (420K shares).
This table shows the top 31 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.

* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.